Sponsor Pipeline

Imunon Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06915025 Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/… Epithelial Ovarian Cancer Recruiting
Phase 1/2
NCT05739981 Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed… Ovarian Cancer Recruiting
NCT03393884 Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer… Epithelial Ovarian Cancer Active, Not Recruiting
Disease Areas
Ovarian Cancer (3)
Get alerts when Imunon's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free